New HER2-negative breast cancer subtype responsive to anti-HER2 therapy identified.
MacNeil, Ian A
New HER2-negative breast cancer subtype responsive to anti-HER2 therapy identified. [electronic resource] - Journal of cancer research and clinical oncology Mar 2020 - 605-619 p. digital
Publication Type: Journal Article
1432-1335
10.1007/s00432-020-03144-7 doi
Animals
Antineoplastic Agents--pharmacology
Biomarkers, Tumor--analysis
Breast Neoplasms--metabolism
Electric Impedance
Female
Humans
Mice
Receptor, ErbB-2--metabolism
Signal Transduction--physiology
Xenograft Model Antitumor Assays
New HER2-negative breast cancer subtype responsive to anti-HER2 therapy identified. [electronic resource] - Journal of cancer research and clinical oncology Mar 2020 - 605-619 p. digital
Publication Type: Journal Article
1432-1335
10.1007/s00432-020-03144-7 doi
Animals
Antineoplastic Agents--pharmacology
Biomarkers, Tumor--analysis
Breast Neoplasms--metabolism
Electric Impedance
Female
Humans
Mice
Receptor, ErbB-2--metabolism
Signal Transduction--physiology
Xenograft Model Antitumor Assays